
928.36MUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US71722W1071
CUSIP
71722W107
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-4.24
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.62
Wall Street Target Price
23.40
EPS Estimate Current Year
-0.08
EPS Estimate Next Year
1.33
EPS Estimate Current Quarter
-0.1943
EPS Estimate Next Quarter
-0.0843
Most Recent Quarter
-
Revenue TTM
204,892,000
Gross Profit TTM
174,020,992
EBITDA
-96,034,000
Profit Margin
-76.77%
Return On Assets TTM
-20.15%
Return On Equity TTM
-3489.00%
Revenue Per Share TTM
2.716
Qtly Revenue Growth YOY
104.40%
Diluted Eps TTM
-1.62
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
3.5655
Price Book MRQ
25.3678
Enterprise Value Revenue
4
Enterprise Value EBITDA
-2
760.00
3.03%22.75
2.52%865.00
0.00%88.94
0.00%124.85
-12.62%259.59
-12.18%853.82
-2.26%187.48
-2.14%476.99
-0.98%204.11
-0.83%